MedPath

Effect of vasa guggulu in Acidity

Phase 3
Completed
Conditions
A newly diagnosed case of Urdhwaga Amlapitta presenting with Avipak,Klama, Tikta-amlaudgaar,Hrit-kanthadaha.
Registration Number
CTRI/2018/01/011416
Lead Sponsor
KLEUS SHRI BMK AYURVEDIC MAHAVIDYALAYASHAHAPURBELGAVI
Brief Summary

**MATERIALS AND METHODS**:

 q  **Studydesign**:

Double Blind RandomizedControl Clinical Trial.

q  **ClinicalData**

A newly diagnosed cases of Urdhwaga Amlapittawill be randomly selected from Opd/Ipd of department of Kayachikitsa of KLEU AyurvedaHospital and research Center Shahapur Belagavi.

 **Vasa Guggulu**:

Willbe prepared in the KLEU’S GMP certifiedAyurveda Pharmacy, Khasbag, Belagavi.

    **SootasekharaRasa**:Will be procured from KLEU GMP certified Ayurveda Pharmacy,Khasbag,Belagavi.

  q  **Literary Data:**

a)Library     b)   Relevant research article   c) Relevant internet related articles.

 q  **SUBJECTS:**

q  Clinical Data

 Newly diagnosed cases of UrdhwagaAmlapittaattending opd/ipd of Kayachikitsa department, KLEU Ayurveda hospital Shahapur Belgavi,fulfilling the inclusion criteria will be enrolled into the study and randomlyassigned into two groups i.e. Group A and Group B.

 q  **Authentication**-

Raw drugs will be authentified in the AYUSH approveddrug laboratory for ASU drugs,Govt of India, K.L.E University Shri B.M.K.Kankanwadi Ayurveda Mahavidyalaya,Belagavi.

 q  **Preparation**-

VasaGuggulu will be prepared as per SOP of KLEU’S GMP certified Ayurveda

Pharmacy,Khasbag,Belagavi.

  q  **Analysis**-

Both raw drug and final product analysis will bedone at AYUSH approved central research facility of K.L.E University  Shri .B.M.K. KankanwadiAyurveda Mahavidyalaya,Belagavi.

q  **SampleSize : 40**

q  **DiagnosticCriteria:**

o  Avipaka

o   Klama

o   Tiktaamlaudgaara

o   Hrut –kanthadaha

 q  **Inclusioncriteria:**

1.     Patient between age group of 20 to 60yrs

2.     A newly diagnosed case of Urdhwaga Amlapittapresenting with Avipak,Klama, Tikta-amlaudgaar,Hrit-kanthadaha.

3.     Irrespective of sex,religion and socio-economicstatus.

                                    q  **Exclusioncriteria:**

 **1.**Patients those who are on NSAID

**2.**Patients suffering from other systemic illness suchas Grahani, Parinamashula,Annadravashulaetc.

**3.**Patients on antacids

4. Pregnant women.

**5.**Lactatingwomen

**GROUP&INTERVENTION INCLUDING FOLLOW UP**

| | | | | |

| --- | --- | --- | --- | --- |

| GROUP

 SAMPLE  SIZE

 INTERVENTION

(0th -30th day)

  DOSE

 FOLLOW UP

|A

20

Vasa guggulu

500mg

15th day

30th day

|B

20

Sootsekhar rasa

250 mg

15th day

30th day

q  **SOPsif any:**

Notapplicable**.**

q  **ASSESSMENTCRITERIA9 :**

**AVIPAKA**

| | |

| --- | --- |

|Grades

Characteristics

|G0

No digestion

|G1

Digests normal usual diet in 9 hours

|G2

Digests normal usual diet in 12 hours

|G3

Digests normal usual diet in 24 hours or more

**KLAMA**

| | |

| --- | --- |

|Grades

Characteristics

|G0

No tiredness

|G1

Feel tired after exertional work

|G2

Feel tired after normal work

|G3

Feel tired even after taking rest

**TIKTA-AMLAUDGAAR**

| | |

| --- | --- |

|G0

No sour and bitter belching

|G1

Sour and bitter belching after taking spicy food

|G2

Sour and bitter belching after taking any type of food

|G3

Sour and bitter belching having no relation with food

 **HRIT-KANTHA DAHA**

| | |

| --- | --- |

|G0

No burning sensation

|G1

Burning sensation after intake of spicy food

|G2

Feeling of burning sensation even after intake of normal food

|G3

Burning sensation on empty stomach

q **Parametric:**

Notapplicable

q  **Nonparametric:**

Avipaka,Klama,Tikta-amlaudgaar,Hritkantadaha

q  **Durationrequired for completing the Study:**

18 month.

 q **StatisticalMethods to analyse the data**:

Analysis will be done as per applicable test.

 q **ExpectedOutcomes:**

Group treated with VasaGuggulu may have better efficacy than group treated with Sootsekhar Rasa.

 q **WithdrawalCriteria**:

Subjects participating in clinical trial will bewithdrawn if there is appearance of either any serious complication or ADR

 q **RescueMedication:**

Minor complication and ADR will be managed in ourhospital with appropriate measures. Major complications will be referred totertiary care centre.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria

A newly diagnosed case of Urdhwaga Amlapitta presenting with Avipak,Klama, Tikta-amlaudgaar,Hrit-kanthadaha.

Exclusion Criteria
  • 1.Patients those who are on NSAID 2.Patients suffering from other systemic illness such as Grahani, Parinamashula,Annadravashulaetc.
  • 3.Patients on antacids 4.Pregnant women.
  • 5.Lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Group treated with Vasa Guggulu has better efficacy than group treated with Sootsekhar Rasa.30 DAYS
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

KLEUS Shri BMK Ayurvedic Mmahavidyalaya

🇮🇳

Belgaum, KARNATAKA, India

KLEUS Shri BMK Ayurvedic Mmahavidyalaya
🇮🇳Belgaum, KARNATAKA, India
DR SUJITSINH MOHITE
Principal investigator
9403259795
drsujitmohite1590@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.